| scholarly article | Q13442814 |
| P50 | author | Mari T Kaartinen | Q61472309 |
| P2093 | author name string | G Melino | |
| V D Myneni | |||
| P2860 | cites work | Inhibition of adipogenesis by Wnt signaling | Q22254771 |
| Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarity | Q24298069 | ||
| Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9 | Q24654674 | ||
| Non-canonical Notch signaling: emerging role and mechanism | Q26863550 | ||
| Transglutaminase 2: an enigmatic enzyme with diverse functions | Q28205648 | ||
| Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment | Q28255124 | ||
| Role of transglutaminase 2 in celiac disease pathogenesis | Q28262529 | ||
| Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation | Q28269495 | ||
| Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2 | Q28364936 | ||
| Pref-1 interacts with fibronectin to inhibit adipocyte differentiation | Q28504692 | ||
| APC-dependent suppression of colon carcinogenesis by PPARgamma | Q28506424 | ||
| Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells | Q81064041 | ||
| FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice | Q81564075 | ||
| Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation | Q42801123 | ||
| Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. | Q42810841 | ||
| Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes | Q42815792 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling | Q42825746 | ||
| Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. | Q42825868 | ||
| Pref-1, a preadipocyte secreted factor that inhibits adipogenesis | Q42833486 | ||
| Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient | Q44120972 | ||
| Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. | Q46455770 | ||
| Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. | Q53566648 | ||
| Differential expression of tissue transglutaminase in human cells. An immunohistochemical study | Q69371038 | ||
| Induction of tissue transglutaminase in mouse peritoneal macrophages | Q72559875 | ||
| Committed subcutaneous preadipocytes are reduced in human obesity | Q79345667 | ||
| LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis | Q28506650 | ||
| Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha | Q28594764 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| It's not how fat you are, it's what you do with it that counts | Q33371764 | ||
| Transglutaminase regulation of cell function. | Q33707936 | ||
| Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity | Q34284044 | ||
| RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling | Q34401105 | ||
| Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway | Q34483657 | ||
| Mechanisms linking obesity with cardiovascular disease | Q34590832 | ||
| Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). | Q34837133 | ||
| Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. | Q35119936 | ||
| Extracellular TG2: emerging functions and regulation | Q35587161 | ||
| Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation | Q35676240 | ||
| Transglutaminase 2: a molecular Swiss army knife | Q35693361 | ||
| Transglutaminase 2 inhibitors and their therapeutic role in disease states | Q35989247 | ||
| Adipogenesis: cellular and molecular aspects. | Q36324040 | ||
| Development of the endochondral skeleton | Q36629738 | ||
| Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy | Q36975456 | ||
| Pref-1, a gatekeeper of adipogenesis | Q36977026 | ||
| Targeted disruption of ROCK1 causes insulin resistance in vivo. | Q37169423 | ||
| Adipogenesis and WNT signalling | Q37325263 | ||
| From mechanotransduction to extracellular matrix gene expression in fibroblasts. | Q37429289 | ||
| Pleiotrophin regulates lung epithelial cell proliferation and differentiation during fetal lung development via beta-catenin and Dlk1. | Q37459908 | ||
| Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis | Q37542905 | ||
| Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. | Q37543851 | ||
| Forming functional fat: a growing understanding of adipocyte differentiation | Q37939532 | ||
| Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications. | Q37972777 | ||
| Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin | Q38297514 | ||
| Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. | Q38338949 | ||
| Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin | Q38408437 | ||
| Gene disruption of tissue transglutaminase | Q39468376 | ||
| Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. | Q39980536 | ||
| Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. | Q40318405 | ||
| Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling | Q40422808 | ||
| Transforming growth factor-beta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression. | Q40434873 | ||
| regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis | Q40499939 | ||
| Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. | Q40638066 | ||
| Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition | Q40771555 | ||
| The Wnt-target gene Dlk-1 is regulated by the Prmt5-associated factor Copr5 during adipogenic conversion | Q41436977 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | adipogenesis | Q2824461 |
| P304 | page(s) | e1868 | |
| P577 | publication date | 2015-08-27 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Transglutaminase 2--a novel inhibitor of adipogenesis | |
| P478 | volume | 6 |
| Q47839477 | Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum. |
| Q92532015 | Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling |
| Q46516735 | Methyl gallate, a potent antioxidant inhibits mouse and human adipocyte differentiation and oxidative stress in adipocytes through impairment of mitotic clonal expansion. |
| Q90389841 | MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling |
| Q38715434 | Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells |
| Q91730183 | Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction |
| Q48305796 | Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow |
Search more.